Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios

Research output: Contribution to journalJournal articlepeer-review

Standard

Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios. / Bender, Anne Mette; Sørensen, Jan; Holm, Astrid; Simonsen, Kenneth; Diderichsen, Finn; Brønnum-Hansen, Henrik.

In: Preventive Medicine Reports, Vol. 19, 101150, 2020.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Bender, AM, Sørensen, J, Holm, A, Simonsen, K, Diderichsen, F & Brønnum-Hansen, H 2020, 'Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios', Preventive Medicine Reports, vol. 19, 101150. https://doi.org/10.1016/j.pmedr.2020.101150

APA

Bender, A. M., Sørensen, J., Holm, A., Simonsen, K., Diderichsen, F., & Brønnum-Hansen, H. (2020). Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios. Preventive Medicine Reports, 19, [101150]. https://doi.org/10.1016/j.pmedr.2020.101150

Vancouver

Bender AM, Sørensen J, Holm A, Simonsen K, Diderichsen F, Brønnum-Hansen H. Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios. Preventive Medicine Reports. 2020;19. 101150. https://doi.org/10.1016/j.pmedr.2020.101150

Author

Bender, Anne Mette ; Sørensen, Jan ; Holm, Astrid ; Simonsen, Kenneth ; Diderichsen, Finn ; Brønnum-Hansen, Henrik. / Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios. In: Preventive Medicine Reports. 2020 ; Vol. 19.

Bibtex

@article{333fd97da0cc4212bc5a86ffa7a49706,
title = "Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios",
abstract = "The aim of this study was to provide decision makers with an assessment of potential future health effects of interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a health impact assessment simulating future prevented disease (ischemic heart disease (IHD), diabetes, stroke, and multi morbidity) incidence, prevalence and life expectancy (LE) related to a scenario where OWOB is reduced by 25% and a scenario where obesity is eliminated. The study covered projected number of persons living in Copenhagen, Denmark during year 2014-2040 (n 2040 = 742,129). Reducing the proportion of men/women with OWOB with 25% will increase population LE by 2.4/1.2 months and at the same time decrease LE with diabetes by 3.1/2.2 months. As a result of eliminating obesity, total LE will increase by 6.0/3.6 months and LE with diabetes will decrease with 9.8/10.3 months for men/women. We found no important effects on LE with IHD and stroke. This illustrates that the positive effects of lowering OWOB levels on IHD and stroke incidence is offset due to increasing total LE. Although the population of Copenhagen is relatively lean, reducing obesity levels will result in significant benefits for population cardiometabolic health status and LE. Future public health prevention programs may use the results as reference data for potential impact of reductions in OWOB.",
author = "Bender, {Anne Mette} and Jan S{\o}rensen and Astrid Holm and Kenneth Simonsen and Finn Diderichsen and Henrik Br{\o}nnum-Hansen",
note = "{\textcopyright} 2020 The Authors.",
year = "2020",
doi = "10.1016/j.pmedr.2020.101150",
language = "English",
volume = "19",
journal = "Preventive Medicine Reports",
issn = "2211-3355",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios

AU - Bender, Anne Mette

AU - Sørensen, Jan

AU - Holm, Astrid

AU - Simonsen, Kenneth

AU - Diderichsen, Finn

AU - Brønnum-Hansen, Henrik

N1 - © 2020 The Authors.

PY - 2020

Y1 - 2020

N2 - The aim of this study was to provide decision makers with an assessment of potential future health effects of interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a health impact assessment simulating future prevented disease (ischemic heart disease (IHD), diabetes, stroke, and multi morbidity) incidence, prevalence and life expectancy (LE) related to a scenario where OWOB is reduced by 25% and a scenario where obesity is eliminated. The study covered projected number of persons living in Copenhagen, Denmark during year 2014-2040 (n 2040 = 742,129). Reducing the proportion of men/women with OWOB with 25% will increase population LE by 2.4/1.2 months and at the same time decrease LE with diabetes by 3.1/2.2 months. As a result of eliminating obesity, total LE will increase by 6.0/3.6 months and LE with diabetes will decrease with 9.8/10.3 months for men/women. We found no important effects on LE with IHD and stroke. This illustrates that the positive effects of lowering OWOB levels on IHD and stroke incidence is offset due to increasing total LE. Although the population of Copenhagen is relatively lean, reducing obesity levels will result in significant benefits for population cardiometabolic health status and LE. Future public health prevention programs may use the results as reference data for potential impact of reductions in OWOB.

AB - The aim of this study was to provide decision makers with an assessment of potential future health effects of interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a health impact assessment simulating future prevented disease (ischemic heart disease (IHD), diabetes, stroke, and multi morbidity) incidence, prevalence and life expectancy (LE) related to a scenario where OWOB is reduced by 25% and a scenario where obesity is eliminated. The study covered projected number of persons living in Copenhagen, Denmark during year 2014-2040 (n 2040 = 742,129). Reducing the proportion of men/women with OWOB with 25% will increase population LE by 2.4/1.2 months and at the same time decrease LE with diabetes by 3.1/2.2 months. As a result of eliminating obesity, total LE will increase by 6.0/3.6 months and LE with diabetes will decrease with 9.8/10.3 months for men/women. We found no important effects on LE with IHD and stroke. This illustrates that the positive effects of lowering OWOB levels on IHD and stroke incidence is offset due to increasing total LE. Although the population of Copenhagen is relatively lean, reducing obesity levels will result in significant benefits for population cardiometabolic health status and LE. Future public health prevention programs may use the results as reference data for potential impact of reductions in OWOB.

U2 - 10.1016/j.pmedr.2020.101150

DO - 10.1016/j.pmedr.2020.101150

M3 - Journal article

C2 - 32685361

VL - 19

JO - Preventive Medicine Reports

JF - Preventive Medicine Reports

SN - 2211-3355

M1 - 101150

ER -

ID: 244997460